Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 201

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 201
---
 outstanding Enfusion Equity Awards; |

| • |     | adopt a plan or agreement of, or resolutions providing for or authorizing, complete or partial liquidation,                                                                                                          
 dissolution, restructuring, merger, consolidation, division, statutory conversion or domestication, share exchange, business combination, reorganization or recapitalization of Enfusion or any of its subsidiaries; |

| • |     | (1) increase or commit to increase the salary, wages, benefits, bonuses or other compensation payable or to                                                                                                                                             
 become payable to Enfusion’s or any of its subsidiaries’ current and former directors, officers, employees, or other non-employee service providers, except (x) as required to be made pursuant to                                                      
 the terms of any Enfusion Employee Plan in effect on the date of the Merger Agreement or (y) pursuant to actions taken to effectuate the treatment of the Enfusion Equity Awards and the ESPP pursuant to the Merger Agreement, including any           
 amendments to the ESPP, (2) become a party to, establish, adopt, amend, commence participation in or terminate any Enfusion Employee Plan or any arrangement that would have been a Enfusion Employee Plan had it been entered into prior to the        
 Merger Agreement (other than with respect to renewal of welfare benefit plans in the ordinary course of business), (3) take any action to accelerate the vesting or lapsing of restrictions or payment, or fund in any other way to secure the payment, 
 of compensation or benefits under any Enfusion Employee Plan, (4) change any actuarial or other assumptions used to calculate funding obligations with respect to any Enfusion Employee Plan that is required by applicable law to be funded, except    
 for any such changes that are required by GAAP (or, in the case of a Foreign Employee Plan, the applicable financial reporting standards) or (5) make any grants under the Enfusion Stock Plan or grant or commit to grant any                          |

128

| change in control, transaction, retention, severance or termination pay, or similar incentive to (or amend any such existing arrangement with) any current or former directors, officers, 
 employees, or other non-employee service providers of Enfusion or its subsidiaries;                                                                                                       |

| • |     | hire, engage, or terminate (other than for cause) the employment/engagement of any employee or independent                                    
 contractor with base salary (in the case of employees) or annual compensation (in the case of independent contractors) in excess of $200,000;